45 results
8-K
EX-10.1
DNTH
Dianthus Therapeutics Inc
22 Jan 24
Dianthus Therapeutics Announces $230 Million Private Placement
7:34am
or the Warrant Shares, including by any form of general solicitation or general advertising.
(ee) Anti-Corruption and Anti-Bribery Laws. Neither the Company … . Foreign Corrupt Practices Act of 1977, as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption Law
8-K/A
EX-99.2
c1q5fvm4hp
20 Sep 23
Results of Operations and Financial Condition
9:50pm
8-K/A
EX-99.1
isu6zhfhn
20 Sep 23
Results of Operations and Financial Condition
9:50pm
424B3
zaimqbwjrf
1 Aug 23
Prospectus supplement
4:42pm
S-4/A
bpjjgoe7xaqs5wefkr
22 Jun 23
Registration of securities issued in business combination transactions (amended)
5:23pm
S-4
848pz 3v4vmsmn2h
15 May 23
Registration of securities issued in business combination transactions
8:39am
425
cn2gxf
3 May 23
Business combination disclosure
7:47am
8-K
EX-2.1
0e8jmk
3 May 23
Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement
7:44am
8-K
EX-10.1
qyvwj60q
12 May 21
Magenta Therapeutics Announces $86.4 Million Common Stock Investment from Multiple Investors
4:31pm